Literature DB >> 7880802

Atypical mycobacterial wound infection after blepharoplasty.

R S Moorthy1, N A Rao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7880802      PMCID： PMC505029          DOI： 10.1136/bjo.79.1.93

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution.

Authors:  T J Safranek; W R Jarvis; L A Carson; L B Cusick; L A Bland; J M Swenson; V A Silcox
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

2.  Mycobacterium fortuitum keratitis.

Authors:  P U Dugel; G N Holland; H H Brown; T H Pettit; J D Hofbauer; K B Simons; H Ullman; P E Bath; R Y Foos
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

3.  Mycobacterium chelonei and orbital granuloma after tear duct probing.

Authors:  R E Smith; J J Salz; R Moors; D Silverstein; W Lewis
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

4.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.

Authors:  B A Brown; R J Wallace; G O Onyi; V De Rosas; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Scleral buckle infections due to atypical mycobacteria.

Authors:  W E Smiddy; D Miller; H W Flynn
Journal:  Retina       Date:  1991       Impact factor: 4.256
  5 in total
  2 in total

1.  Management of cosmetic eyelid surgery complications.

Authors:  Stephen R Klapper; James R Patrinely
Journal:  Semin Plast Surg       Date:  2007-02       Impact factor: 2.314

Review 2.  Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.

Authors:  Wajiha J Kheir; Huda Sheheitli; Maamoun Abdul Fattah; Rola N Hamam
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.